LEXICON PHARMACEUTICALS, INC.

LXRX Net buying

CIK 0001062822 #2543 in the set updated 17 Sep 2026

Bought (120 mo)

$231.30M

out of their own pocket, the only kind of buying there is

Sold (120 mo)

$287.52K

$0.00 on a plan · $287.52K straight out of an exercise

Sold at will

$0.00

0 of 3 sales

Net

+$231.02M

+$231.30M against sales at will

By person

34 insiders · 213 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Artal International S.C.A.

Director

$153.71M (4)

—

+$153.71M

171,583,170

38.56%

$255.66M

+208.7%

Invus Public Equities, L.P.

Director

$65.95M (27)

—

+$65.95M

35,402,689

7.96%

$52.75M

+62.8%

DEBBANE RAYMOND

Director

$5.04M (62)

—

+$5.04M

15,941,740

3.58%

$23.75M

+22.9%

Invus US Partners LLC entity

Director

$2.82M (2)

—

+$2.82M

5,451,204

1.23%

$8.12M

+26.1%

Invus Global Management, LLC entity

Director

$2.00M (1)

—

+$2.00M

1,538,462

0.3458%

$2.29M

—

COATS LONNEL

Chief Executive Officer

$1.11M (46)

—

+$1.11M

1,098,068

0.2468%

$1.64M

—

SOBECKI CHRISTOPHER J

Director

$302.47K (54)

—

+$302.47K

293,177

0.0659%

$436.83K

+8,279%

Tessmer James F

VP, Finance & Accounting

$11.40K (1)

$287.52K (3) scheduled

−$276.12K

71,766

0.0161%

$106.93K

+350.1%

Amouyal Philippe

Director

$201.52K (1)

—

+$201.52K

374,486

0.0842%

$557.98K

+4,035%

WADE JEFFREY L

President and COO

$60.76K (4)

—

+$60.76K

324,214

0.0729%

$483.08K

+885.7%

BARKER SAM L

Director

$40.70K (3)

—

+$40.70K

213,771

0.0480%

$318.52K

+815.8%

McDermott Wendy

SVP, Human Resources

$35.34K (2)

—

+$35.34K

277,945

0.0625%

$414.14K

—

Santini Alexander A

EVP and CCO

$22.40K (3)

—

+$22.40K

55,584

0.0125%

$82.82K

—

Artal Participations S.a r.l.

Director

—

—

—

175,156,062

39.36%

$260.98M

+13.2%

Crum Brian T

SVP, General Counsel & Secr.

—

—

—

428,802

0.0964%

$638.91K

+1,770%

MAIN ALAN J

EVP, Innov & Chem Sciences

—

—

—

339,104

0.0762%

$505.26K

+863.4%

Granowitz Craig B

SVP, Chief Medical Officer

—

—

—

323,430

0.0727%

$481.91K

—

Exton Michael

Chief Executive Officer

—

—

—

298,432

0.0671%

$444.66K

—

Swain Judith L

Director

—

—

—

174,486

0.0392%

$259.98K

+1,827%

Kassler-Taub Kenneth B.

SVP, Regulatory & QA

—

—

—

162,672

0.0366%

$242.38K

+160.4%

Gopinathan Suma

SVP, Discovery

—

—

—

150,132

0.0337%

$223.70K

+101.5%

Sullivan Diane E.

Director

—

—

—

126,122

0.0283%

$187.92K

—

TYLE PRAVEEN

EVP, R&D

—

—

—

120,791

0.0271%

$179.98K

—

Coiante Scott M

SVP, Chief Financial Officer

—

—

—

105,356

0.0237%

$156.98K

—

DeFrancesco Lisa

SVP, IR and Corp Comm

—

—

—

93,869

0.0211%

$139.86K

—

Cheung Ivan

Director

—

—

—

89,312

0.0201%

$133.07K

—

Lapuerta Pablo

EVP and CMO

—

—

—

85,719

0.0193%

$127.72K

+443.7%

Alexander Kristen

VP, Finance and Accounting

—

—

—

76,368

0.0172%

$113.79K

+748.5%

Seth Kiernan

VP, Chief Commercial Officer

—

—

—

53,136

0.0119%

$79.17K

—

LEFKOWITZ ROBERT J MD

Director

—

—

—

48,364

0.0109%

$72.06K

+434.0%

NIES ALAN S

Director

—

—

—

41,046

0.0092%

$61.16K

+320.1%

Palantoni Frank

Director

—

—

—

40,332

0.0091%

$60.09K

+345.3%

Martens Rachel Yap

SVP, Partnerships & Corp Strat

—

—

—

31,264

0.0070%

$46.58K

—

Invus C.V.

Director

—

—

—

0

0.0000%

$0.00

−100.0%

Individual transactions

3

Insider

Date

Role

Action

Shares

Price

Amount

Tessmer James F

15 Mar 2021

VP, Finance & Accounting

Sold after exercise

12,000

$6.93

$83.10K

Tessmer James F

15 Mar 2021

VP, Finance & Accounting

Sold after exercise

10,912

$6.90

$75.34K

Tessmer James F

8 Jun 2018

VP, Finance & Accounting

Sold after exercise

10,000

$12.91

$129.08K

Show all 213 transactions →

What was left out

Form 4 filings counted 343

Amendments (4/A) skipped 0

Filings about a different issuer 0

Unreadable filings 0

Joint filings 22

Sales on a Rule 10b5-1 plan 0

Sales straight out of an exercise 3

Sales at will 0

Transactions with no price 0

Shares from compensation/vesting 114,544,622

History held since 13 Feb 2017